Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Journal Article (Journal Article)

The evolution of prostate cancer from an androgen-dependent state to one that is androgen-independent marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in androgen-independent cancers is poorly understood. We have defined the direct AR-dependent target genes in both androgen-dependent and -independent cancer cells by generating AR-dependent gene expression profiles and AR cistromes. In contrast to what is found in androgen-dependent cells, AR selectively upregulates M-phase cell-cycle genes in androgen-independent cells, including UBE2C, a gene that inactivates the M-phase checkpoint. We find that epigenetic marks at the UBE2C enhancer, notably histone H3K4 methylation and FoxA1 transcription factor binding, are present in androgen-independent cells and direct AR-enhancer binding and UBE2C activation. Thus, the role of AR in androgen-independent cancer cells is not to direct the androgen-dependent gene expression program without androgen, but rather to execute a distinct program resulting in androgen-independent growth.

Full Text

Duke Authors

Cited Authors

  • Wang, Q; Li, W; Zhang, Y; Yuan, X; Xu, K; Yu, J; Chen, Z; Beroukhim, R; Wang, H; Lupien, M; Wu, T; Regan, MM; Meyer, CA; Carroll, JS; Manrai, AK; Jänne, OA; Balk, SP; Mehra, R; Han, B; Chinnaiyan, AM; Rubin, MA; True, L; Fiorentino, M; Fiore, C; Loda, M; Kantoff, PW; Liu, XS; Brown, M

Published Date

  • July 23, 2009

Published In

Volume / Issue

  • 138 / 2

Start / End Page

  • 245 - 256

PubMed ID

  • 19632176

Pubmed Central ID

  • PMC2726827

Electronic International Standard Serial Number (EISSN)

  • 1097-4172

Digital Object Identifier (DOI)

  • 10.1016/j.cell.2009.04.056


  • eng

Conference Location

  • United States